SAGILITY LIMITED

₹ 16,585 million

time by or on behalf of the company.. 2 Performance Highlights Q2 FY26 summary H1 FY26 summary ₹ 16,585 million ₹ 4,352 million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y

₹ 4,352 million

f of the company.. 2 Performance Highlights Q2 FY26 summary H1 FY26 summary ₹ 16,585 million ₹ 4,352 million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.

₹ 3,010 million

2 Performance Highlights Q2 FY26 summary H1 FY26 summary ₹ 16,585 million ₹ 4,352 million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant C

25.2%

FY26 summary H1 FY26 summary ₹ 16,585 million ₹ 4,352 million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26

0%

ary H1 FY26 summary ₹ 16,585 million ₹ 4,352 million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Ma

16.0%

million ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84

11.1 %

ion ₹ 3,010 million Y-o-Y growth 25.2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84.0% ►

26.2%

2% 20..0% at Constant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84.0% ► 16.0% Y-o-Y organic growth in Q2 FY26

18.1%

stant Currency Organic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84.0% ► 16.0% Y-o-Y organic growth in Q2 FY26 driven by expans

25.6%

nic Y-o-Y growth 16.0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84.0% ► 16.0% Y-o-Y organic growth in Q2 FY26 driven by expansion from existing cl

84.0%

0% 11.1 % at Constant Currency Margin % 26.2% Margin % 18.1% Y-o-Y growth 25.6% Y-o-Y growth 84.0% ► 16.0% Y-o-Y organic growth in Q2 FY26 driven by expansion from existing clients, while new wins

₹0.05

ion, consulting-led value creation, and measurable cost take-out initiatives. Interim dividend of ₹0.05 per share ₹ 31,974 million ₹ 8,039 million ₹ 5,007 million Y-o-Y growth 25.5% 21..4% at Const

“H1 FY26 FY25 FY24 FY23 82 9 34 3 75 38 33 10 44 13 30 4 35 7 27 2 TTM Sept 25 FY25 FY24 FY23 63.1% 74.4% 87.6% 8 6 17 51 66.2% 77.9% 90.5% 7 6 12 50 68.3% 79.2% 91.4% 5 7 12 20 72.4% 80.6% 90.7% 4 7 12 12 5 Recent Market Updates Market Changes Impact on Payer/ Provider Likely Impact on Sagility Normalization of tariffs as a long-term policy measure ► Tariff driven increase in cost of imported medical equipment & Pharmaceuticals.”

“Borrowing doesn’t include accrued interest 13 Q2 FY26 Consolidated Profit and Loss Amt in INR M Particulars Revenue from Operation Employee benefits expense* Other expenses^ Adjusted EBITDA** Adjusted EBITDA %”

Note

1

Adjustments

1

Note

Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss). Voluntary attrition (considering employees who were employees for more than 90 days) on an annualized basis 4 Annual KPIs Number of Client groups* Active Number of new client addition (Gross) Delivery sites Number of delivery sites New site addition (Gross) Client groups contribution to revenues Top 3 Client % Top 5 Client % Top 10 Client % Number of Million-dollar client groups Number of clients contributing more than US$20 million Number of clients contributing to US$5 - US$20 million Number of clients contributing to US$1 - US$5 million Number of clients contributing less than US$1 million * Client groups comprise client entities together with their affiliates. H1 FY26 FY25 FY24 FY23 82 9 34 3 75 38 33 10 44 13 30 4 35 7 27 2 TTM Sept 25 FY25 FY24 FY23 63.1% 74.4% 87.6% 8 6 17 51 66.2

Adjustments

M&A Earnouts SAR (stock appreciation right) – Non Cash Other Income^^ Forex Gain / (Loss) Reported EBITDA Finance costs Depreciation and amortisation Profit Before Tax Tax Expenses Reported Profit After Tax EPS Adjusted PAT Adjusted PAT % Adjusted EPS (Rs) Q2 FY26 Q1 FY26 Q2 FY25 YoY% QoQ% H1 26 H1 25 YoY% 16,585 10,070 2,163 4,352 26.2% 127 73 65 516 4,733 250 1,215 3,268 760 2,508 0.54 3,010 18.1% 0.64 15,389 13,250 25.2% 7.8% 9,646 2,056 3,687 24.0% 155 71 50 49 3,560 274 1,182 2,104 618 1,486 0.32 1,997 13.0% 0.43 7,912 1,874 3,465 26.1% 120 93 153 -241 3,165 297 1,264 1,604 431 1,173 0.25 1,636 12.3% 0.35 25.6% 18.0% 49.6% 33.0% 103.7% 55.3% 113.8% 113.8% 84.0% 68.8% 68.8% 50.7% 84.0% 50.7% 31,974 19,715 4,220 8,039 25.1% 283 145 115 566 8,293 524 2,397 5,372 1,378 3,994 0.85 5,007 15.7% 1.07 25,484 15,439 3,664 6,381 25.0% 244 945 189 -32 5,349 671 2,363 2,314 918 1,396 0.31 3,083 12.1% 0.68 25.5% 26.0% 55.0% 132.1% 186.0% 178.3% 62.4% 58.0% *Employee benefits expense excludes M&